Dermatitis News

The FDA’s approval of Eucrisa for atopic dermatitis and Restylane dermal fillers for nasolabial folds were among the most-read articles of the past week on Healio.com/Dermatology.

The FDA announced it has approved Eucrisa ointment to treat mild-to-moderate atopic dermatitis in patients aged 2 years and older.

Regeneron Pharmaceuticals and Sanofi have announced in a press release that the European Medicines Agency has accepted to review the marketing authorization application for Dupixent for treating adults with moderate-to-severe atopic dermatitis who are candidates for systemic therapy.

Sienna Biopharmaceuticals announced it has acquired Creabilis plc, a specialty pharmaceutical company focused on developing topical treatments for inflammatory skin conditions, including psoriasis, atopic dermatitis and pruritus.

Research finding that radiofrequency therapy was as effective as pulsed dye laser in treating rosacea was among the most-read articles of the past week on Healio.com/Dermatology.

Radiofrequency therapy was as effective as pulsed dye laser in treating rosacea, particularly in patients with papulopustular rosacea, according to published study results.

In recognition of World AIDS Day, Healio.com/Dermatology is highlighting reports of dermatologic research and development in HIV-positive patients.

Research finding that treatment with Xeljanz in adolescents with alopecia areata resulted in significant hair regrowth for the majority of the patients, with mild adverse events, was among the most-read articles so far this month on Healio.com/Dermatology.

The American Society for Dermatologic Surgery Association recognized physicians with Patient Safety Hero and Federal Advocate awards at the ASDS annual meeting in New Orleans.

The FDA’s clearance of Syneron Candela's microneedling device for appearance of cellulite was among the most-read articles of the past week on Healio.com/Dermatology.